Teleflex Incorporated TFX posted fourth-quarter 2024 adjusted earnings per share (EPS) from continuing operations of $3.89, ...

Teleflex Incorporated (NYSE: TFX) has announced its agreement to acquire BIOTRONIK’s Vascular Intervention business in a ...

Teleflex to create a new, independent publicly traded company consisting of its Urology, Acute Care, and OEM businesses.

Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...

Teleflex Inc (TFX) reports a 2.8% revenue increase and a 15.1% rise in adjusted EPS, while announcing a strategic acquisition and share repurchase program to drive future growth.

After the split, Teleflex would focus on devices for bloodstream and heart procedures, along with medical imaging, while ...

Citizens JMP downgraded Teleflex (TFX) to Market Perform from Outperform without a price target The company this morning reported Q4 results ...

Good morning, ladies and gentlemen, and welcome to the Teleflex Fourth Quarter 2024 Earnings Conference Call. At this time all participants have been placed in a listen-only mode. At the end of the ...

Brainomix announced today that it entered into a strategic partnership with the Medtronic Neurovascular business unit.

Teleflex experienced a dramatic 20% stock plunge on Thursday, hitting a new 52-week low of $136.60. Despite slightly exceeding analyst expectations with an adjusted earnings per share of $3.89, the ...

Teleflex's business units, including urology and acute care will come under NewCo, with interventional and surgical under ...